Nice misleading headline. The titers are lower than Sinovac, and some monkeys (3 out of 6) did exhibit symptoms but no one of them had lung damage. Also, for re

Nice misleading headline. The titers are lower than Sinovac, and some monkeys (3 out of 6) did exhibit symptoms but no one of them had lung damage. Also, for reasons I can't understand, the dosage was half the one used in the human trial. Oxford will, according to a statement, also try multiple administrations, exactly like one arm of their trial. Lastly, some protection is better than no protection. Personally I'd wait for the trial results before saying, falsely, that it fails to stop the virus.